Related Experiment Video
Updated: Aug 9, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44
Dirk O Watermann1, Yesheng Tang, Axel Zur Hausen
1Department of Obstetrics and Gynecology, University of Freiburg, Freiburg, Germany.
Abstract:
The human CD44 gene undergoes extensive alternative splicing of multiple variable exons positioned in a cassette in the middle of the gene. Expression of alternative exons is often restricted to certain tissues and could be associated with tumor progression and metastasis of several human malignancies, including breast cancer. Exon v4 contains multiple copies of a C/A-rich exon enhancer sequence required for optimal inclusion of the exon and binding to the nucleic acid-binding proteins YB-1 and human Tra2-beta1. Here, we show that hTra2-beta1, a member of the extended family of serine/arginine-rich (SR) splicing factors, enhances the in vivo inclusion of CD44 exons v4 and v5. It increased inclusion of exons v4 and v5 and acted synergistically with YB-1. Activation required the C/A-rich enhancer within exon v4. Several other SR proteins had none or only a slight effect on CD44 exon inclusion. In contrast, SC35 inhibited exon usage and antagonized the effects of Tra2 or YB-1. In a matched pair analysis of human breast cancers and their corresponding nonpathologic tissue controls, we found a significant induction of Tra2-beta1 in invasive breast cancer, both on the RNA and protein levels. Together with our functional data, these results suggest an important role for Tra2-beta1 in breast cancer. Induction of this splicing factor might be responsible for splicing of CD44 isoforms associated with tumor progression and metastasis.
Insights
The splicing factor Tra2-beta1 enhances CD44 exon inclusion, particularly in breast cancer. Its increased expression in tumors suggests a role in cancer progression and metastasis.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Splicing
Background:
- The CD44 gene exhibits extensive alternative splicing, involving variable exons crucial for various cellular functions.
- Aberrant splicing of CD44 is linked to tumor progression and metastasis in several human cancers, including breast cancer.
- Exon v4 of CD44 contains enhancer sequences essential for its inclusion and binding of specific nucleic acid-binding proteins.
Purpose of the Study:
- To investigate the role of the serine/arginine-rich (SR) splicing factor human Tra2-beta1 (hTra2-beta1) in the alternative splicing of CD44.
- To determine if hTra2-beta1 influences the inclusion of CD44 exons v4 and v5.
- To assess the expression levels of hTra2-beta1 in human breast cancer tissues compared to non-pathologic controls.
Main Methods:
- In vivo splicing assays were performed to evaluate the effect of hTra2-beta1 on CD44 exon v4 and v5 inclusion.
- The synergistic effects of hTra2-beta1 with YB-1 protein were examined.
- Matched pair analysis of human breast cancer and nonpathologic tissue samples was conducted to quantify Tra2-beta1 RNA and protein levels.
Main Results:
- hTra2-beta1 significantly enhanced the in vivo inclusion of CD44 exons v4 and v5, acting synergistically with YB-1.
- The enhancer sequence within exon v4 was required for hTra2-beta1-mediated activation.
- A significant induction of Tra2-beta1 was observed in invasive breast cancer tissues at both RNA and protein levels compared to controls.
Conclusions:
- hTra2-beta1 plays a key role in promoting the inclusion of CD44 exons v4 and v5, potentially through interaction with enhancer elements.
- The elevated expression of Tra2-beta1 in breast cancer suggests its involvement in the generation of CD44 isoforms associated with tumor progression.
- These findings highlight Tra2-beta1 as a potential factor contributing to breast cancer metastasis.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Pre-mRNA Processing: RNA Splicing

